Related Experiment Video
Updated: Nov 5, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
Extracellular vesicles as drug vectors for precise cancer treatment
Xin-Hui Cao1,2, Ming-Xing Liang1, Yang Wu3
1Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, PR China.
Abstract:
Extracellular vesicles (EVs) are nano-sized vesicle structures secreted from a variety of cells, which carry numerous biological macromolecules, participate in cell signal transduction and avoid immune system clearance. EVs have a plethora of specific signal recognition factors, and many studies have shown that they can play an important role in the precise treatment of tumors. This review aims to compile the applications of EVs as nanocarriers for antitumor drugs, gene drugs and other nanomaterials with anticancer capability. Additionally, we systematically summarize the preparation methodology and expound upon how to improve the drug loading and cancer-targeting capacity of EVs. We highlight that EV-based drug delivery has the potential to become the future of precise cancer treatment.
Insights
Extracellular vesicles (EVs) are natural nanocarriers for targeted cancer therapy. This review explores their use in delivering antitumor drugs and nanomaterials for precise cancer treatment.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Extracellular vesicles (EVs) are nano-sized vesicles secreted by cells.
- EVs carry biomolecules and mediate intercellular communication.
- They possess unique properties for potential therapeutic applications, including cancer treatment.
Purpose of the Study:
- To review the applications of EVs as nanocarriers for anticancer drugs and nanomaterials.
- To summarize EV preparation methods and strategies for enhancing drug loading and targeting.
- To highlight the potential of EV-based drug delivery in precise cancer therapy.
Main Methods:
- Literature review of studies on EVs in cancer therapy.
- Systematic summary of EV preparation techniques.
- Analysis of methods to improve EV drug loading and cancer targeting.
Main Results:
- EVs can serve as effective nanocarriers for antitumor drugs, gene drugs, and other anticancer nanomaterials.
- Various preparation methodologies for EVs are available.
- Strategies exist to optimize drug loading efficiency and cancer-targeting specificity of EVs.
Conclusions:
- EV-based drug delivery shows significant promise for precise and effective cancer treatment.
- Further research into EV preparation and functionalization can enhance their therapeutic potential.
- EVs represent a promising frontier in the development of next-generation cancer therapies.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

